NFL Biosciences SAS

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0014003XT0
EUR
1.04
-0.05 (-4.94%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
NFL Biosciences SAS Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
Profit Before Tax
-2.00
-4.00
-2.00
-1.00
0.00
Adjustment
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
0.00
0.00
0.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
0.00
0.00
0.00
0.00
0.00
Cash Flow from Investing Activities
0.00
0.00
0.00
0.00
0.00
Cash Flow from Financing Activities
0.00
0.00
0.00
0.00
0.00
Net Cash Inflow / Outflow
0.00
0.00
0.00
0.00
0.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of NFL Biosciences SAS
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Profit Before Tax
-2.716249
-15.3087000001411
13.00
82.26%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0
3.94870000003639
-3.00
-100.00%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
0
-10.1060000000931
10.00
100.00%
Cash Flow from Investing Activities
0
-0.0250000000002304
0.00
100.00%
Cash Flow from Financing Activities
0
6.35800000005859
-6.00
-100.00%
Net Cash Inflow / Outflow
0
-3.7659000000347
3.00
100.00%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0.0071000000000654
0.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
0.00
0.00
0.00%